Abstract
Objective: This study mainly aims to assess and evaluate risk factors, clinical and therapeutical profile in chronic obstructive pulmonary disease (COPD) patients and promote rational drug therapy; to identify the prevalence of COPD symptoms and to assess the drugs prescribed in treating COPD patients; and to evaluate patterns of diagnosing COPD in patients and determine the severity of COPD in patients using COPD assessment test (CAT).
 Methods: A prospective observational study conducted in government general hospital among 220 patients for 6 months. Data were collected from patients by CAT questionnaire through interviewing each subject.
 Results: The majority of the patients (36%) were in the age group of 71–80 years. Males are more prone to the COPD (91%). Most common initiation interdependence of these habits are 31–40 years and 61.8% are suffering with comorbidities. A total of 145 (65%) have social habits. About 68% of the patients are suffering from occupational exposure, 78% of the patients are suffering from old pulmonary problems.
 Conclusion: Clinical pharmacist main provision is providing care to individual patients by patient counseling, regarding the rational usage of drug and also providing proper education regarding the usage of nebulizers and creating awareness to the patients.
Highlights
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide
We categorize the prescriptions into genderwise distribution, age-wise distribution, and based on risk factors and clinical manifestations
The following data or tables indicate that how many patients affected with this disease with different signs and symptoms and risk factors
Summary
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is a progressive disease characterized by airflow limitation that is not fully reversible and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases. COPD is the fourth leading cause of death worldwide and will be third leading cause of death by 2020. COPD attributed to active smoking, ambient particulate matter pollution, household air pollution, second-hand smoke, and lead exposure was responsible for about 3.46 million of global deaths and 9.78 million of disability-adjusted life years in 2017. The goals of the GOLD organization are to increase awareness of COPD and reduce morbidity and mortality associated with the disease [2]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
